News
GOTHENBURG, SE / ACCESS Newswire / July 10, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report April-June 2025. The ...
Peer review is the core quality control mechanism of science, determining what gets published and funded. Yet, the system is ...
AI Health R&D, Consecutive Blockbuster Auctions, and Record Authentication Demand Signal Breakout Quarter for MDCE and Its High-Growth Subsidiaries. MESA, ARIZONA / ACCESS Newswire / July 10, 2025 / ...
New integration brings Guardant Health's complete oncology testing portfolio into the VieCure Halo Intelligence platform, streamlining access to precision diagnostics at the point of care DENVER, CO / ...
Live demos of Morpheus8, Emsculpt NEO, and other treatments will accompany a talk on cellular wellness and anti-aging at ...
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally approved for CID, to regulatory approval and commercialization for general ...
UltraClear laser is now available at The Naderi Center, offering safe, effective skin resurfacing for all skin tones with reduced downtime and heat-related risks. CHEVY CHASE, MARYLAND / ACCESS ...
Ainos Pioneers SmellTech as the Next Sensory Frontier in Industrial AI2H 2025 Industrial Pilots and Subscription Model Poised to Unlock Multi-Million Dollar Revenue Potential in 2026 SAN DIEGO, ...
Zomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – Ocala
Elevating Equine Health and Show Experience with Leading Shock Wave Therapy ANN ARBOR, MI / ACCESS Newswire / July 10, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary ...
Epitopea, a transatlantic cancer immunotherapeutics company, has announced the formation of a dedicated clinical team and the ...
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, today announced the formation of its dedicated clinical team and the ...
Proceeds will advance clinical development of Nuclidium’s true theranostic pipeline and expand its global production and manufacturing network for copper-based radiopharmaceuticalsParticipation is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results